Ben completed his undergraduate degree in Chemical Biology at McMaster University, working with Dr. Jim McNulty during his final year on the development of CYP19A1 (aromatase) inhibitors as hormone-dependant breast cancer therapeutics. Sparking his love for research at the interface of chemistry and biology, he joined Dr. Mark Nitz’s lab in 2011. Since that time, he has worked on diverse projects related to the biosynthesis of the PNAG polysaccharide, encompassing structure-based drug design, virtual screening, traditional and protecting-group free carbohydrate synthesis, and assay design. Outside the lab, Ben enjoys craft beer, board games, listening to new music, and exploring Toronto’s restaurant scene. His favourite things are Björk, the Food & Drink magazine, and hiking.